Chemed(CHE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CHE Chemed

Not Yet Opened 11-21 16:00:00 EST

563.28

+10.41

+1.88%

盘后563.28

+0.000.00%

16:20 EST

High565.40	Low551.03	Vol120.42K
Open551.03	D1 Closing552.87	Amplitude2.60%
Mkt Cap8.41B	Tradable Cap8.26B	Total Shares14.93M
T/O67.57M	T/O Rate0.82%	Tradable Shares14.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CHE","market":"US","secType":"STK","nameCN":"Chemed","latestPrice":563.28,"timestamp":1732222800000,"preClose":552.87,"halted":0,"volume":120420,"hourTrading":{"tag":"盘后","latestPrice":563.28,"preClose":563.28,"latestTime":"16:20 EST","volume":910,"amount":512584.8,"timestamp":1732224000586},"delay":0,"floatShares":14668020,"shares":14927604,"eps":19.782585,"marketStatus":"Not Yet Opened","change":10.41,"latestTime":"11-21 16:00:00 EST","open":551.03,"high":565.4,"low":551.03,"amount":67571068.43232,"amplitude":0.025992,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":19.782585,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732266000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":552.87,"dividendRate":0.003018,"preHourTrading":{"tag":"盘前","latestPrice":556.5,"preClose":552.87,"latestTime":"08:00 EST","volume":5,"amount":2771.18,"timestamp":1732194022809},"postHourTrading":{"tag":"盘后","latestPrice":563.28,"preClose":563.28,"latestTime":"16:20 EST","volume":910,"amount":512584.8,"timestamp":1732224000586},"volumeRatio":1.413015,"impliedVol":0.2124,"impliedVolPercentile":0.7052},"requestUrl":"/m/hq/s/CHE","defaultTab":"news","newsList":[{"id":"2482438061","title":"Chemed Declares $300 Million Addition to Share-Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2482438061","media":"Dow Jones","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482438061?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:51","pubTimestamp":1731088260,"startTime":"0","endTime":"0","summary":"Chemed said it would add $300 million of company shares to its existing buy back program.The owner of VITAS Healthcare and Roto-Rooter on Friday said its board approved the addition to the stock-repurchase program, which would be funded through its cash resources and its revolving credit facility.In addition, the company declared a quarterly cash dividend of 30 cents, payable on Dec. 6.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","IE00BLDYK493.USD","BK4196","CHE"],"gpt_icon":0},{"id":"2482385474","title":"Chemed Approves $300 Million in Additional Stock Repurchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2482385474","media":"MT Newswires Live","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482385474?lang=en_us&edition=fundamental","pubTime":"2024-11-09 01:36","pubTimestamp":1731087376,"startTime":"0","endTime":"0","summary":"Chemed  said Friday its board has approved $300 million in additional stock repurchases.The company plans to fund the repurchase program with its cash from operations and revolving credit facility.Chemed maintained its quarterly dividend at $0.50 per share, payable Dec. 6 to shareholders of record as of Nov. 18.Price: 557.89, Change: +3.16, Percent Change: +0.57","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B64QTZ34.USD","BK4196","CHE","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"2482948455","title":"BRIEF-Chemed Board Authorizes Additional $300 Million For Stock Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2482948455","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482948455?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:45","pubTimestamp":1731084338,"startTime":"0","endTime":"0","summary":"BRIEF-Chemed Board Authorizes Additional $300 Million For Stock RepurchaseNov 8 (Reuters) - Chemed Corp CHE.N:CHEMED CORPORATION BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $300 MILLION FOR STOCK REPU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nTUA5HY9WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHE","IE00BLDYK493.USD","IE00B64QTZ34.USD","BK4196"],"gpt_icon":0},{"id":"2482702438","title":"Chemed declares $0.50 dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702438","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482702438?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:44","pubTimestamp":1731084297,"startTime":"0","endTime":"0","summary":"Chemed (NYSE:CHE) declares $0.50/share quarterly dividend, in line with previous.\n\nForward yield 0.36%\nPayable Dec. 6; for shareholders of record Nov. 18; ex-div Nov. 18.\nSee CHE Dividend Scorecard, Yield Chart, & Dividend Growth.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4267237-chemed-declares-050-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["CHE","IE00BLDYK493.USD","IE00B64QTZ34.USD","BK4196"],"gpt_icon":0},{"id":"2482843624","title":"Chemed : Repurchases Will Be Funded Through Cash Generated From Ops, Utilization of Revolving Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2482843624","media":"THOMSON REUTERS","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482843624?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:43","pubTimestamp":1731084180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nTUA5HY9WK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHE","BK4196","IE00BLDYK493.USD","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2482810194","title":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents","url":"https://stock-news.laohu8.com/highlight/detail?id=2482810194","media":"THOMSON REUTERS","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482810194?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:43","pubTimestamp":1731084180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nTUA5HY9WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLDYK493.USD","CHE","BK4196","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2482482131","title":"Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents","url":"https://stock-news.laohu8.com/highlight/detail?id=2482482131","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482482131?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:43","pubTimestamp":1731084180,"startTime":"0","endTime":"0","summary":"CINCINNATI, November 08, 2024----Chemed Corporation  announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation  operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bE6l1FQIpoDE8PELjy9ZZg--~B/aD03OTE7dz0yNDI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/466f39b9519b636f53a620698460389c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bE6l1FQIpoDE8PELjy9ZZg--~B/aD03OTE7dz0yNDI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/466f39b9519b636f53a620698460389c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chemed-corporation-board-directors-authorizes-164300623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64QTZ34.USD","IE00BLDYK493.USD","BK4196","CHE"],"gpt_icon":0},{"id":"2481964684","title":"Top Research Reports for Shopify, Sherwin-Williams & Fortinet","url":"https://stock-news.laohu8.com/highlight/detail?id=2481964684","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481964684?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:28","pubTimestamp":1730928480,"startTime":"0","endTime":"0","summary":"Wednesday, November 6, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Shopify In","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DD2luz_hkhr6AJ7USAki8Q--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c14fca54f39fa1e806adce0884bc1059","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DD2luz_hkhr6AJ7USAki8Q--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c14fca54f39fa1e806adce0884bc1059"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-research-reports-shopify-sherwin-212800893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SHW","LU1023057109.AUD","BK4533","LU2008162690.USD","LU0070302665.USD","ALGT","HBB","LU0211331839.USD","BK4201","SHOP","LU2023250843.SGD","SPR","JAZZ","ANF","LU2023250504.SGD","FTNT","LU1093756325.SGD","BK4526","LU0162691827.USD","LU2279701549.SGD","LU0348825331.USD","IE00B0JY6N72.USD","LU2357305700.SGD","IE00BLDYK493.USD","LU0208291251.USD","IE00B64QTZ34.USD","LU1861219969.SGD","BK4187","CHE","LU1489326972.SGD","LU0823426308.USD","LU2177674079.SGD","MTZ","ST","LU1804176565.USD","WTW","YUMC","IE00BGV7N243.SGD","LU0061475181.USD","E","LU1917777945.USD","LU2106854487.HKD","BK4550","LU0320765992.SGD","HII","BK4129","FAF","BK4500","BK4173","BK4116"],"gpt_icon":0},{"id":"2481638383","title":"Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2481638383","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481638383?lang=en_us&edition=fundamental","pubTime":"2024-11-06 01:00","pubTimestamp":1730826000,"startTime":"0","endTime":"0","summary":"CINCINNATI, November 05, 2024----Chemed Corporation  today announced that it will deliver a presentation at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m.  at the Terranea Resort in Rancho Palos Verdes, California.Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation  operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4_MH9iVa3RkkDv0YHvz8VQ--~B/aD03OTE7dz0yNDI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/130e34e949f159c90834a8fb3a8e2ca9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4_MH9iVa3RkkDv0YHvz8VQ--~B/aD03OTE7dz0yNDI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/130e34e949f159c90834a8fb3a8e2ca9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chemed-corporation-present-ubs-2024-170000301.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","BK4196","IE00BLDYK493.USD","CHE","IE00B64QTZ34.USD","BK4581","BK4585","BK4588","BK4561","BK4144","HCSG","BK4590","ET"],"gpt_icon":0},{"id":"2481683764","title":"Chemed price target lowered to $633 from $697 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2481683764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481683764?lang=en_us&edition=fundamental","pubTime":"2024-11-05 22:45","pubTimestamp":1730817911,"startTime":"0","endTime":"0","summary":"RBC Capital lowered the firm’s price target on Chemed (CHE) to $633 from $697 and keeps an Outperform rating on the shares after its Q3 earnings. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/chemed-price-target-lowered-to-633-from-697-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/chemed-price-target-lowered-to-633-from-697-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHE"],"gpt_icon":0},{"id":"2481530141","title":"AMED or CHE: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481530141","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481530141?lang=en_us&edition=fundamental","pubTime":"2024-11-05 00:40","pubTimestamp":1730738419,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys  and Chemed . But which of these two companies is the best option for those looking for undervalued stocks?Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.Amedisys has a Zacks Rank of #2 , while Chemed has a Zacks Rank of #3  right now. This means that AMED's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one factor that value investors are interested in.AMED currently has a forward P/E ratio of 20.53, while CHE has a forward P/E of 22.81. We also note that AMED has a PEG rati","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amed-che-better-value-stock-164019506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHE","BK4196","AMED","IE00BLDYK493.USD","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2479029437","title":"We Ran A Stock Scan For Earnings Growth And Chemed (NYSE:CHE) Passed With Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=2479029437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479029437?lang=en_us&edition=fundamental","pubTime":"2024-10-31 18:50","pubTimestamp":1730371814,"startTime":"0","endTime":"0","summary":"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.In contrast to all that, many investors prefer to focus on companies like Chemed , which has not only revenues, but also profits. While this doesn't necessarily speak to whether it's undervalued, the profitability of the business is enough to warrant some appreciation - especially if its growing.While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in the US with promising g","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ran-stock-scan-earnings-growth-105014464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHE","NYSE"],"gpt_icon":0},{"id":"2479946702","title":"Chemed Third Quarter 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2479946702","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479946702?lang=en_us&edition=fundamental","pubTime":"2024-10-31 18:47","pubTimestamp":1730371648,"startTime":"0","endTime":"0","summary":"NYSE:CHE Earnings and Revenue History October 31st 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 3.5%.Looking ahead, revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in the US.The company's shares are down 9.7% from a week ago.You still need to take note of risks, for example - Chemed has   1 warning sign   we think you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chemed-third-quarter-2024-earnings-104728715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHE"],"gpt_icon":0},{"id":"2479722814","title":"Chemed Corp (CHE) Q3 2024 Earnings Call Highlights: VITAS Shines Amid Roto-Rooter's Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722814","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479722814?lang=en_us&edition=fundamental","pubTime":"2024-10-31 15:10","pubTimestamp":1730358640,"startTime":"0","endTime":"0","summary":"VITAS Net Revenue: $391.4 million, an increase of 17.3% year-over-year.VITAS Admissions: 16,775, a 6.3% increase from the prior year.Average Daily Census  for VITAS: 21,785 patients, a 15.5% increase year-over-year.Roto-Rooter Revenue: $214.8 million, a decrease of 6.9% year-over-year.Roto-Rooter Residential Revenue: $146 million, a decrease of 6.3% year-over-year.Roto-Rooter Commercial Revenue: $53.5 million, a decrease of 5.9% year-over-year.Adjusted EBITDA for VITAS: $73.1 million, an increase of 33.1%.Adjusted EBITDA Margin for VITAS: 18.6%, an increase of 212 basis points year-over-year.Adjusted EBITDA for Roto-Rooter: $56.4 million, a decrease of 15.8% year-over-year.Adjusted EBITDA Margin for Roto-Rooter: 26.3%, a decline of 275 basis points year-over-year.Full-Year 2024 Earnings Per Diluted Share Guidance: $23 to $23.15, representing a 13.3% to 14% increase from 2023.Chemed Corp  reduced its full-year 2024 earnings guidance due to continued softness in Roto-Rooter's performance","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chemed-corp-che-q3-2024-071040121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHE"],"gpt_icon":0},{"id":"2479728815","title":"Q3 2024 Chemed Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2479728815","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479728815?lang=en_us&edition=fundamental","pubTime":"2024-10-31 13:54","pubTimestamp":1730354086,"startTime":"0","endTime":"0","summary":"Holley R. Schmidt; Vice President and Assistant Controller; Chemed Corp. Kevin J. McNamara; President and Chief Executive Officer; Chemed Corp. Michael D. Witzeman; Vice President, Chief Financial Officer, and Controller; Chemed Corp. Nicholas M. Westfall; Executive Vice President; Chemed Corp. Good day, and thank you for standing by, and welcome to the Chemed Corporation Third Quarter 2024 earnings conference call. At this time, all participants are in listen only mode. After the speakers' presentation, there will be a question-and-answer session to ask a question. During this session, you'll need to press star one on your telephone. You will then hear an automated message advising your hands raised. To withdraw your question, please press star one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Holley R. Schmidt can add Assistant Controller. Please go ahead.Thank you, Holley, and good mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-chemed-corp-earnings-055446618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GOOGL","GOOG","CHE"],"gpt_icon":0},{"id":"2479736794","title":"CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2479736794","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479736794?lang=en_us&edition=fundamental","pubTime":"2024-10-30 22:16","pubTimestamp":1730297760,"startTime":"0","endTime":"0","summary":"Chemed Corporation CHE reported third-quarter 2024 adjusted earnings per share  of $5.64, which rose 6% year over year. However, the figure missed the Zacks Consensus Estimate by 2.1%.The company’s GAAP EPS was $5.00, up 1.4% from last year’s reported figure.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, CHE stock rose marginally 0.2% yesterday.Revenues in the reported quarter improved 7.4% year over year to $606.2 million. The metric missed the Zacks Consensus Estimate by 1.1%.In the third quarter, net revenues totaled $391.4 million, up 17.3% year over year.The segment reported sales of $214.8 million, down 6.9% year over year.Total Roto-Rooter branch commercial revenues decreased 5.9% year over year. This consisted of a 4.4% decline in drain cleaning revenues, a 12.1% fall in plumbing, a 2.3% drop in excavation and a 3.3% decrease in water restoration.The gross profit increased 3.9% year over year to $210 million in the th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z9cpClmJQHpcjlETszUEbA--~B/aD00NjU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z9cpClmJQHpcjlETszUEbA--~B/aD00NjU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/che-misses-q3-earnings-lowers-141600406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CHE"],"gpt_icon":0},{"id":"1130582024","title":"Stock Track | Chemed Stock Plunges as Q3 Earnings Miss Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1130582024","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130582024?lang=en_us&edition=fundamental","pubTime":"2024-10-30 21:44","pubTimestamp":1730295899,"startTime":"0","endTime":"0","summary":"Shares of Chemed Corporation  took a significant hit on Tuesday, plummeting by 5.71% as the company reported its third-quarter financial results for the period ended September 30, 2024. The stock's decline came in response to the company's weaker-than-expected earnings and revenue figures.Chemed reported adjusted earnings per share  of $5.64 for the quarter, missing analysts' consensus estimate of $5.76. The company's revenue rose 7.4% year-over-year to $606.18 million, but it fell short of Wall","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["CHE"],"gpt_icon":0},{"id":"2479205068","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Chemed (CHE) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479205068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479205068?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:50","pubTimestamp":1730289056,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Harmony Biosciences Holdings (HRMY – Research Report...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-chemed-che-and-incyte-incy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-chemed-che-and-incyte-incy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4196","HCSG","BK4532","INCY","BK4007","BK4137","BK4588","IE00BLDYK493.USD","HRMY","IE00B64QTZ34.USD","CHE","BK4550"],"gpt_icon":0},{"id":"2479691279","title":"Chemed’s Robust Vitas Growth and Strategic Opportunities Justify Buy Rating Despite Roto Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2479691279","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479691279?lang=en_us&edition=fundamental","pubTime":"2024-10-30 18:12","pubTimestamp":1730283167,"startTime":"0","endTime":"0","summary":"In a report released today, Joanna Gajuk from Bank of America Securities reiterated a Buy rating on Chemed (CHE – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chemeds-robust-vitas-growth-and-strategic-opportunities-justify-buy-rating-despite-roto-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chemeds-robust-vitas-growth-and-strategic-opportunities-justify-buy-rating-despite-roto-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CHE"],"gpt_icon":0},{"id":"2479564215","title":"Chemed Corp reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2479564215","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479564215?lang=en_us&edition=fundamental","pubTime":"2024-10-30 10:59","pubTimestamp":1730257150,"startTime":"0","endTime":"0","summary":"* Chemed Corp    reported quarterly adjusted earnings of $5.64 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $5.32.  The mean e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Chemed Corp reports results for the quarter ended in September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chemed.com","stockEarnings":[{"period":"1week","weight":0.0018},{"period":"1month","weight":-0.051},{"period":"3month","weight":-0.0159},{"period":"6month","weight":0.0142},{"period":"1year","weight":-0.03},{"period":"ytd","weight":-0.0367}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.590909,"avgChangeRate":0.022464},{"month":2,"riseRate":0.568182,"avgChangeRate":0.020191},{"month":3,"riseRate":0.568182,"avgChangeRate":0.00465},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.005996},{"month":5,"riseRate":0.577778,"avgChangeRate":0.022388},{"month":6,"riseRate":0.622222,"avgChangeRate":0.013244},{"month":7,"riseRate":0.4,"avgChangeRate":-0.006888},{"month":8,"riseRate":0.555556,"avgChangeRate":0.006257},{"month":9,"riseRate":0.422222,"avgChangeRate":-0.010428},{"month":10,"riseRate":0.577778,"avgChangeRate":0.015057},{"month":11,"riseRate":0.666667,"avgChangeRate":0.027934},{"month":12,"riseRate":0.522727,"avgChangeRate":0.02283}],"exchange":"NYSE","name":"Chemed","nameEN":"Chemed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chemed(CHE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Chemed(CHE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Chemed,CHE,Chemed股票,Chemed股票老虎,Chemed股票老虎国际,Chemed行情,Chemed股票行情,Chemed股价,Chemed股市,Chemed股票价格,Chemed股票交易,Chemed股票购买,Chemed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chemed(CHE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Chemed(CHE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}